Summary
Parents are worried after the FDA rejected some treatments for rare diseases, which affects many children. The FDA insists that thorough evidence is needed before approving treatments to ensure safety and effectiveness.
Key Facts
- The FDA has denied approval of certain treatments for rare diseases, causing concern among parents.
- Many parents of children with rare diseases fear losing access to necessary treatments.
- Rare diseases affect about 30 million Americans, with many impacted individuals being children.
- The FDA says it requires strong data from well-controlled trials to approve treatments safely.
- The FDA has introduced reforms to speed up innovation in rare disease treatments.
- Since January 2025, the FDA issued 23 complete response letters, indicating refusals or delays in drug approvals.
- Senator Ron Johnson plans to investigate the FDA's actions regarding rare disease treatment approvals.
- PGA golfer Akshay Bhatia dedicated his tournament win to his niece who had a rare disease and passed away.
